Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2022 | 1 |
2023 | 2 |
2024 | 2 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Decitabine in combination with fludarabine and cyclophosphamide as a lymphodepletion regimen followed by CD19/CD22 bispecific targeted CAR T-cell therapy significantly improves survival in relapsed/refractory B-ALL patients.
Exp Hematol Oncol. 2023 Apr 10;12(1):36. doi: 10.1186/s40164-023-00397-z.
Exp Hematol Oncol. 2023.
PMID: 37038230
Free PMC article.
Long-term follow-up of tandem CD19/CD22 CAR T-Cells in r/r B-ALL patients with high-risk features.
Cui W, Zhang XY, Li Z, Dai HP, Yin J, Cui QY, Liu SN, Kang LQ, Yu L, Wu DP, Tang XW.
Cui W, et al.
Am J Hematol. 2023 Nov;98(11):E338-E340. doi: 10.1002/ajh.27076. Epub 2023 Sep 4.
Am J Hematol. 2023.
PMID: 37665759
No abstract available.
Item in Clipboard
CD7-directed CAR T-cell therapy: a potential immunotherapy strategy for relapsed/refractory acute myeloid leukemia.
Cao X, Dai H, Cui Q, Li Z, Shen W, Pan J, Shen H, Ma Q, Li M, Chen S, Chen J, Zhu X, Meng H, Yang L, Wu D, Tang X.
Cao X, et al.
Exp Hematol Oncol. 2022 Sep 29;11(1):67. doi: 10.1186/s40164-022-00318-6.
Exp Hematol Oncol. 2022.
PMID: 36175988
Free PMC article.
Item in Clipboard
[Efficacy and safety of chimeric antigen receptor T-cell therapy followed by allogeneic hematopoietic stem cell transplantation in 21 patients with Ph-like acute lymphoblastic leukemia].
Dai HP, Shen HJ, Li Z, Cui W, Cui QY, Li MY, Chen SF, Zhu MQ, Wu DP, Tang XW.
Dai HP, et al.
Zhonghua Xue Ye Xue Za Zhi. 2024 Jan 14;45(1):35-40. doi: 10.3760/cma.j.cn121090-20230929-00154.
Zhonghua Xue Ye Xue Za Zhi. 2024.
PMID: 38527836
Chinese.
Item in Clipboard
Successful treatment of a B/T MPAL patient by chemo-free treatment with venetoclax, azacitidine, and blinatumomab.
Liu S, Cui Q, Li M, Li Z, Chen S, Wu D, Tang X.
Liu S, et al.
Ann Hematol. 2024 Apr;103(4):1397-1402. doi: 10.1007/s00277-024-05644-9. Epub 2024 Feb 17.
Ann Hematol. 2024.
PMID: 38367057
Free PMC article.
Item in Clipboard
CAR-T therapy bridging to allogeneic HSCT provides durable molecular remission of Ph+ mixed phenotype acute leukaemia with minimal residual disease.
Kong D, Qu C, Dai H, Li Z, Yin J, Chen S, Kang L, Chen G, Zhu M, Yu L, Wu D, Tang X.
Kong D, et al.
Br J Haematol. 2020 Oct;191(2):e47-e49. doi: 10.1111/bjh.16982. Epub 2020 Jul 22.
Br J Haematol. 2020.
PMID: 32700338
Free article.
Clinical Trial.
No abstract available.
Item in Clipboard
Cite
Cite